Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725996 | SCV000341100 | uncertain significance | not provided | 2016-05-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001087652 | SCV000650944 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000407717 | SCV000719563 | likely benign | not specified | 2017-06-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000725996 | SCV002545557 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BS2 |
ARUP Laboratories, |
RCV000725996 | SCV003799337 | likely benign | not provided | 2022-10-20 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150153 | SCV003838368 | benign | Cardiomyopathy | 2021-09-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003957485 | SCV004770385 | likely benign | FLNC-related disorder | 2020-09-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |